Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
1.510
-0.090 (-5.63%)
At close: Apr 23, 2026, 4:00 PM EDT
1.520
+0.010 (0.66%)
Pre-market: Apr 24, 2026, 4:27 AM EDT
Invivyd Employees
Invivyd had 122 employees as of December 31, 2025. The number of employees increased by 22 or 22.00% compared to the previous year.
Employees
122
Change (1Y)
22
Growth (1Y)
22.00%
Revenue / Employee
$437,918
Profits / Employee
-$430,238
Market Cap
427.03M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 122 | 22 | 22.00% | 122 | 0 |
| Dec 31, 2024 | 100 | 5 | 5.26% | 99 | 1 |
| Dec 31, 2023 | 95 | 9 | 10.47% | 94 | 1 |
| Dec 31, 2022 | 86 | -17 | -16.50% | 84 | 2 |
| Dec 31, 2021 | 103 | - | - | 101 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Ginkgo Bioworks Holdings | 485 |
| REGENXBIO | 371 |
| Entrada Therapeutics | 152 |
| Armata Pharmaceuticals | 60 |
| Lexeo Therapeutics | 59 |
| Altimmune | 57 |
| Atea Pharmaceuticals | 55 |
IVVD News
- 4 days ago - Invivyd Announces Chairman Marc Elia to Speak at POLITICO Health Care Summit - GlobeNewsWire
- 14 days ago - Invivyd Stock Surges As FDA Alignment Boosts COVID-19 Program - Benzinga
- 15 days ago - Invivyd Announces REVOLUTION Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate VMS063 for Treatment and Prevention of Measles - GlobeNewsWire
- 18 days ago - Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 24 days ago - Invivyd Announces Presentation at the World Vaccine Congress Washington - GlobeNewsWire
- 7 weeks ago - Invivyd Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Recent Business Highlights and DECLARATION Clinical Trial Updates - GlobeNewsWire
- 7 weeks ago - Invivyd Appoints Distinguished Physician and Scientist, Michael Mina, M.D., Ph.D. as Chief Medical Officer - GlobeNewsWire
- 7 weeks ago - Invivyd to Host Fourth Quarter and Full-Year 2025 Financial Results and Corporate Update Conference Call on March 5, 2026 - GlobeNewsWire